Thrombolytic Medicines for Pulmonary Embolism - Topic Overview
Thrombolytic medicines, such as streptokinase, urokinase, or
tissue-type plasminogen activator (t-PA), interfere with the action of
thrombin, which is needed to form blood clots. These medicines help to dissolve
blood clots and may be used to treat
pulmonary embolism in life-threatening situations.
Research continues on the best use of thrombolytics to treat
pulmonary embolism. All thrombolytics can cause serious bleeding. Bleeding
inside the brain is a particular danger that can cause a stroke or death. In
general, thrombolytics are used only where the risk of bleeding can be balanced
against the risks of not dissolving the blood clot rapidly. Thrombolytics might be used when you have a large blood clot that is:
Recommended Related to Lung Disease/Respiratory Problems
It is possible that the main title of the report Cystic Fibrosis is not the name you expected. Please check the synonyms listing to find the alternate name(s) and disorder subdivision(s) covered by this report.
These medicines are given through a vein in the hand or arm.
Occasionally it is necessary to insert a catheter and give the medicine
directly into the pulmonary artery. You must be hospitalized to receive